BAIYUNSHAN PH plans to develop an advanced manufacturing center in Hong Kong
The Investment Promotion Agency held a Traditional Chinese Medicine Development Forum yesterday (8th), gathering over 150 industry stakeholders to discuss topics such as the transformation of Traditional Chinese Medicine research, clinical practice, and standard formulation. Chen Zhizhao, General Manager of Guangzhou Pharmaceutical Baiyunshan Hong Kong Co., Ltd., a subsidiary of Baiyunshan (00874.HK), stated at the event that the group is currently engaged in production and manufacturing in Macau, using Macau as a base to develop trade business targeting Portuguese-speaking countries and Latin America. He also revealed plans to develop an advanced manufacturing center project in Hong Kong to expand into the UK and US markets
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments